Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles

Journal of Drug Delivery Science and Technology

Volumn 32, Issue , 2016, Pages 283-290

  Dalpiaz, Alessandro ^a   Sacchetti, Francesca ^b   Baldisserotto, Anna ^a   Pavan, Barbara ^a   Maretti, Eleonora ^b   Iannuccelli, Valentina ^b   Leo, Eliana ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Diclofenac sodium; Lauric acid; N6 Cyclopentyladenosine; Nanoprecipitation; Poly(lactic glycolic) acid (PLGA, PLA); Protamine

Indexed keywords

6 N CYCLOPENTYLADENOSINE; DICLOFENAC; LAURIC ACID; POLYLACTIDE; POLYMER; PROTAMINE SULFATE;

ARTICLE; DRUG DEGRADATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HYDROPHILICITY; IN OIL NANOPRECIPITATION; IN VITRO STUDY; MOLECULAR WEIGHT; NANOENCAPSULATION; NORMAL HUMAN; PARTICLE SIZE; PRECIPITATION;

EID: 84961602232     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2015.07.020     Document Type: Article

References (47)

1. L. Milane, S. Ganesh, S. Shaha, Z. Duanb, and M. Amijia Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology J. Control. Release 155 2011 237 247
2. S.P. Egusquiaguirre, M. Igartua, R.M. Hernández, and J.L. Pedraz Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research Clin. Transl. Oncol. 14 2012 83 93
3. J. Kreuter Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv. Drug. Del. Rev. 71 2014 2 14
4. I. Bala, S. Hariharan, and M.N.V. Ravi Kumar PLGA nanoparticles in drug delivery: the state of the art Crit. Rev. Ther. Drug Carr. Syst. 21 2004 387 422
5. S. Acharya, and S.K. Sahoo PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect Adv. Drug. Del. Rev. 63 2011 170 183
6. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347
7. A. Minost, J. Delaveau, M.A. Bolzinger, H. Fessi, and A. Elaissari Nanoparticles via nanoprecipitation process Recent Pat. drug Deliv. Formul. 6 2012 250 258
8. T. Govender, S. Stolnik, M.C. Garnett, L. Illum, and S.S. Davis PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug J. Control. Release 57 1999 171 185
9. T. Betancourt, B. Brown, and L. Brannon-Peppas Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation Nanomedicine 2 2007 219 232
10. G. Tosi, L. Costantino, F. Rivasi, B. Ruozi, E. Leo, A.V. Vergoni, R. Tacchi, A. Bertolini, M.A. Vandelli, and F. Forni Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 J. Control. Release 122 2007 1 9
11. M.N. Koopaei, R. Dinarvand, M. Amini, H. Rabbani, S. Emami, S.N. Ostad, and F. Atyabi Docetaxel -immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies Int. J. Nanomed. 6 2011 1903 1912
12. K.S. Yadav, S. Jacob, G. Sachdeva, K. Chuttani, A.K. Mishra, and K.K. Sawant Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia J. Microencapsul. 28 2011 729 742
13. U. Seju, A. Kumar, and K.K. Sawant Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies Acta Biomater. 7 2011 4169 4176
14. J. Lalani, Y. Raichandani, R. Mathur, M. Lalan, K. Chutani, A.K. Mishra, and A. Misra Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles J. Biomed. Nanotechnol. 8 2012 918 927
15. W. Geldenhuys, D. Wehrung, A. Groshev, A. Hirani, and V. Sutariya Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers Pharm. Dev. Technol. 20 4 Jun 2015 497 506
16. T. Govender, T. Riley, T. Ehtezazi, M.C. Garnett, S. Stolnik, L. Illum, and S.S. Davis Defining the drug incorporation properties of PLA-PEG nanoparticles Int. J. Pharm. 199 2000 95 110
17. T. Govender, T. Riley, S. Stolnik, M.C. Garnett, L. Illum, and S.S. Davis PLA-PEG nanoparticles for site specific delivery: drug incorporation study J. Control. Release 64 2000 318 319
18. Y. Kawashima, H. Yamamoto, H. Takeuchi, T. Hino, and T. Niwa Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods Eur. J. Pharm. Biopharm. 45 1998 41 48
19. T. Niwa, H. Takeuchi, T. Nino, N. Kunou, and Y. Kawashima Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with dl-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior J. Control. Release 25 1993 89 98
20. P.A. Grabnar, and J. Kristl The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers J. Microencapsul. 28 2011 323 335
21. U. Bilati, E. Allémann, and E. Doelker Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles Eur. J. Pharm. Sci. 24 2005 67 75
22. T.J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev. Ind. Pharm. 25 1999 471 476
23. L. Peltonen, J. Aitta, S. Hyvönen, M. Karjalainen, and J. Hirvonen Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(l)lactidenanoparticles AAPS PharmSciTech 5 2004 115 120
24. A. Sansukcharearnpon, S. Wanichwecharungruang, N. Leepipatpaiboon, T. Kerdcharoen, and S. Arayachukeat High loading fragrance encapsulation based on a polymer-blend: preparation and release behavior Int. J. Pharm. 391 2010 267 273
25. 6-cyclopentyladenosine-loaded nanoparticles J. Pharm. Sci. 98 2009 4272 4284
26. 1 receptor agonist Pharm. Res. 18 2001 531 536
27. S. Wang, S. Guo, and L. Cheng Disodium norcantharidate loaded (polycaprolactone) microspheres: I. Preparation and evaluation Int. J. Pharm. 350 2008 130 137
28. Y. Samati, N. Yuksel, and N. Tarimci Preparation and characterization of poly (D,L-lactic-co-glycolic acid) microspheres containing flurbiprofen sodium Drug Deliv. 13 2006 105 111
29. C. Yan, D. Chen, J. Gu, and J. Qin Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization - In-vitro drug release and anti-tumour activity J. Pharm. Pharmacol. 58 2006 1177 1181
30. P. Costa, and J.M. Sousa Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2001 123 133
31. A. Dalpiaz, E. Leo, F. Vitali, B. Pavan, A. Scatturin, F. Bortolotti, S. Manfredini, E. Durini, F. Forni, B. Brina, and M.A. Vandelli Development and characterization of biodegradable nanoparticles as delivery systems of antiischemic adenosine derivatives Biomaterials 26 2005 1299 1306
32. E. Leo, C. Contado, F. Bortolotti, B. Pavan, A. Scatturin, G. Tosi, S. Manfredini, A. Angusti, and A. Dalpiaz Nanoparticle formulation may affect the stabilization of an antiischemicprodrug Int. J. Pharm. 307 2006 103 113
33. 1 receptor agonist J. Control. Release 73 2001 303 313
34. A. Dalpiaz, M. Mezzena, A. Scatturin, and S. Scalia Solid lipid microparticles for the stability enhancement of the polar drug N(6)-cyclopentyladenosine Int. J. Pharm. 355 2008 81 86
35. U. Bilati, E. Allémann, and E. Doelker Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method-processing and formulation issues for enhanced entrapment efficiency J. Microencapsul. 22 2005 205 214
36. Y. Tsuchiya, T. Ishti, Y. Okahata, and T. Sato Characterization of protamine as atransfection accelerator for gene delivery J. Bioact. Compat. Polym. 21 2006 519 537
37. M. Hull, K. Lieb, and B.L. Fiebich Antiinflammatory drugs: a hope for Alzheimer's disease? Expert Opin. Invest. Drugs 9 2000 671 683
38. D. Jaturapatporn, M.G. Isaac, J. McCleery, and N. Tabet Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease Cochrane Database Syst. Rev. 2 2012 CD 006378
39. 1 receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system Curr. Med. Chem. 9 2002 1923 1927
40. K.A. Jacobson, B.K. Trivedi, P.C. Churchill, and M. Williams Novel therapeutics acting via purinergic receptors Biochem. Pharmacol. 41 1991 1399 1410
41. M.S. Brodie, K. Lee, B.B. Fredholm, L. Stahle, and T.V. Dunwiddie Central versus peripheral mediation of responses to receptor agonists: evidence against a central mode of action Brain Res. 415 1987 323 330
42. B. Pavan, and A.P. IJzerman Processing of adenosine receptor agonists in rat and human whole blood Biochem. Pharmacol. 56 1998 1625 1632
43. A. Dalpiaz, E. Gavini, G. Colombo, P. Russo, F. Bortolotti, L. Ferraro, S. Tanganelli, A. Scatturin, E. Menegatti, and P. Giunchedi Brain uptake of an anti-ischemic agent by nasal administration of microparticles J. Pharm. Sci. 97 2008 4889 4903
44. C.E. Mora-Huertas, O. Garrigues, H. Fessi, and A. Elaissari Nanocapsules prepared via nanoprecipitation and emulsification-diffusion methods: comparative study Eur. J. Pharm. Biopharm. 80 2012 235 239
45. M. Gaumet, A. Vargas, R. Gurny, and F. Delie Nanoparticles for drug delivery: the need for precision in reporting particle size parameters Eur. J. Pharm. Biopharm. 6 2008 1 9
46. F. Alexis Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid) Polym. Int. 54 2005 36 46
47. R.C. Mundargi, V.R. Babu, V. Rangaswamy, P. Patel, and T.M. Aminabhavi Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives J. Control. Release 125 2008 193 209